-
Recent Posts
- Clean Air Act – Power Performance Enterprises Fined
- US Auto Sales Forecast Trump Bump or Bumpy 25?
- Toyota Slashes 2025 Electric Vehicle Prices $6000
- Kenworth, Peterbuilt ABS Software Recall
- November Global Light Vehicle Sales Rate 93 Million
- Airports – More Safety, Capacity Improvements On Way
- Florida Man Pleads Guilty to Odometer Tampering
- December U.S. Auto Sales Start Strong
- Technical Tidbits – Porsche 1900 Wheel-Hub Motor
- French are Running Nissan Americas and in Japan
- GM About Face on Robo Taxi Development
- Stellantis and CATL JV for LFP Battery Plant in Spain
- Mustang GTD Laps Nürburgring in under Seven Minutes
- Tavares Out. Stellantis Back into ACEA!
- US Light Vehicle Sales Strong in November
Recent Comments
- Lisa Jacobson on Fossil Fuel Phase Out or Cop Out at COP28?
- Stellantis on Carlos Tavares Out as Stellantis CEO
- NHTSA Fines Ford $165M for Flouting Recall Law | AutoInformed on Ford Recalls Defective Rear-view Cameras on 620,246 Vehicles
- Alfa Romeo Returns to Formula 1 in 2018 via Sauber on Alfa Romeo Returns to Formula 1 in 2018 via Sauber
- American Airlines and JetBlue Alliance Blocked | AutoInformed on Justice Sues to Block JetBlue’s Purchase of Spirit Airlines
Archives
Meta
Get intelligent commentary on the automobile business and its economic and social effects. Stay informed with AutoInformed.
Covid – Commerce NIST Grant of $153 million to National Institute for Innovation in Manufacturing Biopharmaceuticals
NIIMBL* will work to increase the shelf life and reduce the amount of refrigeration required for messenger RNA vaccines, boost capabilities for rapid production of antigens used in testing and screening for new variants and develop novel technologies for detecting counterfeit vaccines, among other things. Continue reading →